Contributor

Ron Kwok

Ron Kwok

Partner, Healthcare & Life Sciences

Fast Pharma: The Cost of Coming in Second in Clinical Trials

Fast Pharma: The Cost of Coming in Second in Clinical Trials

Modern biopharma is shifting from a marathon to a sprint — where second place costs billions. 

READ ARTICLE →

11 min read

May 2026

Healthcare & Life Sciences

Research & Development

Strategy